Matches in Wikidata for { <http://www.wikidata.org/entity/Q91301541> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91301541 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91301541 description "scientific article published on 02 November 2019" @default.
- Q91301541 description "wetenschappelijk artikel" @default.
- Q91301541 description "наукова стаття, опублікована 2 листопада 2019" @default.
- Q91301541 name "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 name "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 type Item @default.
- Q91301541 label "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 label "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 prefLabel "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 prefLabel "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 P1433 Q91301541-E8805B17-6C2A-4161-A5B6-5B057B46BB13 @default.
- Q91301541 P1476 Q91301541-A9F5D47C-349A-4514-951D-ECCF17900000 @default.
- Q91301541 P2093 Q91301541-12D41FF7-DE4A-481A-A556-4185CCAE529D @default.
- Q91301541 P2093 Q91301541-5C4C2C58-2921-465C-BC9B-95382B763347 @default.
- Q91301541 P2093 Q91301541-6112B715-93EC-4F3E-94A9-BC7CDB65926D @default.
- Q91301541 P2093 Q91301541-91F88ED4-7DC2-45F6-91AA-ACE6C9FD9ACD @default.
- Q91301541 P2093 Q91301541-A68DF6F5-8AE8-40FB-80D4-635CE5E0F808 @default.
- Q91301541 P2093 Q91301541-EC0F362C-422F-4FD6-A0D9-CC427716E57C @default.
- Q91301541 P2860 Q91301541-A4A160B4-8E06-4029-8E19-DBF2F613DF08 @default.
- Q91301541 P304 Q91301541-7D9BA498-9277-44E5-8BB1-C3B731D6E132 @default.
- Q91301541 P31 Q91301541-67868665-6690-459C-BA99-AF2A309F09B3 @default.
- Q91301541 P356 Q91301541-C108D146-DBD7-45D3-8BEC-2002858AD450 @default.
- Q91301541 P478 Q91301541-1F40A486-C037-48F9-B78D-4CFD3CC87EEF @default.
- Q91301541 P577 Q91301541-76146236-CB9F-4E51-890F-3341DB50A4D9 @default.
- Q91301541 P698 Q91301541-F64A246E-6158-4514-BF5F-52E3C4B74EDF @default.
- Q91301541 P921 Q91301541-54AC41E5-BAE2-44E2-9E32-88911505CF5C @default.
- Q91301541 P356 J.DRUGALCDEP.2019.107709 @default.
- Q91301541 P698 31732295 @default.
- Q91301541 P1433 Q5308875 @default.
- Q91301541 P1476 "Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system" @default.
- Q91301541 P2093 "Jennifer R Havens" @default.
- Q91301541 P2093 "Jiangwen Sun" @default.
- Q91301541 P2093 "Michelle R Lofwall" @default.
- Q91301541 P2093 "Rachel Vickers-Smith" @default.
- Q91301541 P2093 "Richard J Charnigo" @default.
- Q91301541 P2093 "Sharon L Walsh" @default.
- Q91301541 P2860 Q58892027 @default.
- Q91301541 P304 "107709" @default.
- Q91301541 P31 Q13442814 @default.
- Q91301541 P356 "10.1016/J.DRUGALCDEP.2019.107709" @default.
- Q91301541 P478 "206" @default.
- Q91301541 P577 "2019-11-02T00:00:00Z" @default.
- Q91301541 P698 "31732295" @default.
- Q91301541 P921 Q64910143 @default.